Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone

Sexually Transmitted Diseases

Volumn 39, Issue 10, 2012, Pages 813-821

  Starnino, Stefania ^a,b   Irene Pagano, ^c   Valdir Monteiro Pinto, ^d,e   Maria Elena Realpe ^f   Rafael Llanes, ^g   Onelquis Feliciano, ^g   Eduardo Aguilar Jarrin, ^h   Nicolas Aguayo, ⁱ   Ana Acevedo, ^j   Mingmin Liao, ^a   Galarza, Patricia ^c   Carvallo, María Elena Trigoso ^k   Benzaken, Adele Schwartz ^l   Ballesteros, Aurora Maldonado ^m   Cruz, Olga Marina Sanabria ^f   Hernandez, Alina Llop ^g   Carbajal, José Luis Portilla ⁿ   Borthagaray, Graciela ^j   Payares, Daisy ^o   Dillon, Jo Anne R ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^d Division STD Control Hepatitis and Aids Departamiento National ITS/SIDA   (Brazil)

^e STD/AIDS State Program   (Brazil)

^f INSTITUTO NACIONAL DE SALUD   (Colombia)

^g INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^h Ministerio de Salud Publica Del Ecuador   (Ecuador)

ⁱ Ministerio de Salud de Paraguay   (Paraguay)

^j UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^k Programa de ITS VIH SIDA   (Bolivia)

^l Fundção Alfredo da Matta   (Brazil)

^m INSTITUTO DE SALUD PÚBLICA DE CHILE   (Chile)

ⁿ INSTITUTO NACIONAL DE SALUD   (Peru)

^o Instituto Nacional de Higiene Rafael Rangel   (Venezuela)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; OFLOXACIN; PENICILLIN G; SPECTINOMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CENTRAL AMERICA; GONORRHEA; HUMAN; NEISSERIA GONORRHOEAE; NONHUMAN; PRACTICE GUIDELINE; RECOMMENDED DRUG DOSE; RETROSPECTIVE STUDY; SOUTH AND CENTRAL AMERICA; TREND STUDY;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CARIBBEAN REGION; CEFTRIAXONE; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; FEMALE; GONORRHEA; HEALTH PLANNING GUIDELINES; HUMANS; LATIN AMERICA; MALE; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SENTINEL SURVEILLANCE;

EID: 84866701174     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3182631c9f     Document Type: Article

References (45)

1. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug-And extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther 2009; 7:821-834.
2. Workowski KA, Berman SM, Douglas JM Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: Urgent need to strengthen prevention strategies. Ann Intern Med 2008; 148:606-613. (Pubitemid 351669134)
3. Lewis DA. The gonococcus fights back: Is this time a knock out? Sex Transm Infect 2010; 86:415-421.
4. Centers for Disease Control, Prevention. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Morb Mortal Wkly Rep 2006; 55:1-94.
5. Centers for Disease Control and Prevention. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: Fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep 2007; 56:332-336.
6. Bignell CJ. BASHH guideline for gonorrhoea. Sex Transm Infect 2004; 80:330-331. (Pubitemid 39389546)
7. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: The impending problem of resistance. Expert Opin Pharmacother 2009; 10:555-577.
8. Ohnishi M, Golparian D, Shimuta K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011;55:3538-3545.
9. BolanGA, Sparling PF,Wasserheit JN. The emerging threat of untreatable gonococcal infection. N Engl J Med 2012; 366:485-487.
10. Lo Yokoi S, Deguchi T, Ozawa T, et al. Threat to cefixime treatment of gonorrhea. Emerg Infect Dis 2007; 13:1275-1277.
11. Unemo M, Golparian D, Syversen G, et al. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhea treatment, Norway 2010. Euro Surveill 2010; 15:pii:19721.
12. Ison CA, Hussey J, Sankar KN, et al. Gonorrhea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill 2010; 16:pii:19833.
13. Unemo M, Golparian D, Stary A, et al. First Neisseria gonorrhoeae with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill 2011; 16:pii:19998.
14. Public Health Agency of Canada. Gonococcal infections, last update December 21, 2011. Available at: http://www.phac-Aspc.gc.ca/stdmts/sti-its/ alert/2011/alert-gono-eng.php.
15. Bignell C, FitzGerald M. UK national guideline for the management of gonorrhea in adults, 2011. Available at http://www.bashh.org/documents/3470/ 3470.pdf. Accessed February 9, 2012.
16. Workowski KA, Berman S. Centers for Disease control and prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Morb Mortal Wkly Rep 2010; 59(RR-12):1-10.
17. Chisholm S, Quaye N, Cole M, et al. An evaluation of gentamicin susceptibility Neisseria gonorrhoeae isolates in Europe. J Antimicrob Chemother 2011; 66:592-595.
18. Ross JDC, Lewis DA. Cephalosporin resistant N. gonorrhoeae: time to consider gentamicin? Sex Transm Infect 2012; 88:6-8.
19. Dillon JR, Li H, Sealy J, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St Vincent Sex Transm Dis 2001; 28: 508-514. (Pubitemid 32852655)
20. Dillon JR, Rubabaza JPA, Benzaken AS, et al. Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998. Sex Transm Dis 2001; 28:521-526. (Pubitemid 32852657)
21. Sosa J, Ramirez-Arcos S, Ruben M, et al. High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995-1998. Sex Transm Dis 2003; 30:443-448. (Pubitemid 36605495)
22. Márquez C, Xia M, Borthagaray G, et al. The first molecular characterization of tetracycline-resistant Neisseria gonorrhoeae from Uruguay. J Antimicrob Chemother 1996; 37:839-841. (Pubitemid 26134133)
23. Moreno JG, Dillon JR, Arroyave R, et al. Identification of penicillinase-producing Neisseria gonorrhoeae (PPNG) in Chile during clinical and micro-biological investigations of gonococcal susceptibility to antimicrobial agents. Genitourin Med 1987; 63:6-12. (Pubitemid 17009029)
24. Dillon JR, Ruben M, Li H, et al. Challenge in the control of gonorrhea in South America and the Caribbean: Monitoring the development of resistance to antibiotics. Sex Transm Dis 2006; 33:87-95.
25. Garcia PJ, Benzaken AS, Galban E, et al. STI management and control in Latin America: where do we stand and where do we go from here? Sex Transm Infect 2011; 87:ii7-ii9.
26. Llanes R, Sosa J,GuzmanD, et al. Neisseria gonorrhoeae resistant to ciprofloxacin: first report in Cuba. Sex Transm Dis 2001; 28:82-83. (Pubitemid 32151903)
27. Llanes R, Zamora A, Nápoles M, et al. Antimicrobial resistance of Neisseria gonorrhoeae in the municipality of Morón, Cuba: Emergence of isolates with intermediate resistance to fluoroquinolones. J Antimicrob Chemother 2003; 51:191-192. (Pubitemid 36163855)
28. Fiorito S, Galarza P, Pagano I, et al. Emergence of high level ciprofloxacin resistant Neisseria gonorrhoeae strain in Buenos Aires, Argentina. Sex Transm Infect 2001; 77:77. (Pubitemid 32142797)
29. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: 19th Informational Supplement M100-S19. Wayne, PA: Clinical and Laboratory Standards Institute, 2009.
30. Dillon JR, Li H, Yeung KH, et al. A PCR assay for discriminating Neisseria gonorrhoeae beta-lactamase-producing plasmid. Mol Cell Probes 1999; 13:89-92. (Pubitemid 29206406)
31. Meeting ReportWorkshop for the Revitalization of the Gonococcal Antimicrobial Susceptibility Surveillance Program in Latin America and Caribbean (GASP-LAC), 2-4 November 2010, Buenos Aires, Argentina. Available at: http://www.gasp-lac.net. Accessed November 21, 2011.
32. Unemo M, Fasth O, Fredlund H, et al. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother 2009; 63:1142-1151.
33. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2007 Supplement, Gonococcal Isolate Surveillance Project (GISP) Annual Report 2007. Atlanta, GA: G US Department of Health and Human Services, Centers for Disease Control and Prevention; 2009. Available at: http://www.cdc.gov/std/GISP2007. Accessed December 14, 2011.
34. Barreto NA, Sant'anna RPR, Silva BGL, et al. Phenotypic and molecular characterization of Neisseria gonorrhoeae isolated in Rio de Janeiro, Brazil, 2002-2003. DST J Bras Doencas Sex Transm 2004; 16:32-42.
35. Rice RJ, Knapp JS. Susceptibility of Neisseria gonorrhoeae associated with pelvic inflammatory disease to cefoxitin, ceftriaxone, clindamycin, gentamicin, doxycycline, azithromycin, and other antimicrobial agents. Antimicrob Agents Chemother 1994; 38:1688-1691. (Pubitemid 24203596)
36. World Health Organization (WHO) 2011. Prevalence and incidence in 2005 of selected sexually transmitted infections: Methods and results WHO Geneva, Switzerland. Available at: http://whqlibdoc.who.int/publications/2011/ 9789241502450-eng.pdf. Accessed January 18, 2012.
37. Uehara AA, Amorin ELT, Ferreira MF, et al. Molecular characterization of quinolone-resistant Neisseria gonorrhoeae isolates from Brazil. J Clin Microbiol 2011; 49:4208-4242.
38. FerreiraWA, Ferreira CM, Naveca FG, et al. Genotyping of two Neisseria gonorrhoeae fluoroquinolone-resistant strains in the Brazilian Amazon Region. Mem Inst Oswaldo Cruz 2011; 106:629-631.
39. Moran JS, Levine WC. Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin Infect Dis 1995; 20:S47.
40. Thakur SD, Liao M, Nagle E, et al. Identification of a Neisseria gonorrhoeae population susceptible to antibiotics traditionally used to treat gonococcal infections: Will regional control strategies be relevant? Presented at 12th Biennal conference of the International Union against Sexually Transmitted Infections (IUSTI) EO14: 55; 2011; New Delhi, India.
41. Galarza PG, Alcala B, Salcedo C, et al. Emergence of high level azithromycin-resistance Neisseria gonorrhoeae strain isolated in Argentina. Sex Transm Dis 2009; 36:787-788.
42. Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhea verified by international recommendations, Sweden, July 2010. Euro Surveill 2011; 16:pii:19792.
43. Centers for Disease Control and Prevention. Notice to readers: discontinuation of spectinomycin. MMWR Morb Mortal Wkly Rep 2006; 55:370.
44. Boslego JW, Tramont EC, Takafuji ET, et al. Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinaseproducing N. gonorrhoeae. N Engl J Med 1987; 317:272-278. (Pubitemid 17100106)
45. Ison CA. Antimicrobial agents and gonorrhea: therapeutic choice, resistance and susceptibility testing. Genitourin Med 1996; 72: 253-257. (Pubitemid 26290723)